angiotensin-converting enzyme 2

Quinapril hydrochloride (PD-109452-2) 是一种血管紧张素转化酶(ACE) 抑制剂的原药。

Resorcinolnaphthalein 是一种特异性的血管紧张素转换酶 2 激活剂，EC50=19.5 μM。Resorcinolnaphthalein 能够用于高血压和肾纤维化的研究

SARS-CoV-2-IN-109 (compound 50) 是一种针对 SARS-CoV 的抑制剂，具有体内对抗感染的活性。它通过影响 SARS-CoV-2 Spike 受体结合域 (RBD) 与人类受体血管紧张素转换酶 2 (ACE2) 的相互作用来发挥作用，EC50 为 26.5 μM，并阻止 SARS-CoV-2 进入 VeroE6 细胞，ECS50 为 17.0 μM。此外，SARS-CoV-2-IN-109 对 VeroE6 细胞的 CC50 大于 100 μM。

DX600 是一种angiotensin-converting enzyme 2 (ACE2)的特异抑制剂，不会与ACE 发生交叉反应。

Angiotensin I/II (1-6) TFA is a chemical compound comprising amino acids 1-6. It is derived from the Angiotensin I/II peptide, which is formed by the cleavage of the precursor angiotensinogen by renin. The resulting Angiotensin I is then hydrolyzed by angiotensin-converting enzyme (ACE) to produce biologically active Angiotensin II. Angiotensin II has been extensively studied for its potential applications in the treatment of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy[1][2][3].

SSAA09E1 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) viral entry.1It reduces infection of HEK293T cells transiently transfected with angiotensin-converting enzyme 2 (ACE2) by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50= 6.7 μM). SSAA09E1 also inhibits the proteolytic activity of cathepsin L (IC50= 5.33 μM) but not cathepsin B when used at a concentration of 20 μM. 1.()

Vicenin 2 来源于广金钱草 (Desmodium styracifolium) 的地上部分。Vicenin 2 是一种血管紧张素转换酶 (ACE) 抑制剂，IC50=43.83 μM。

Peimisine (Ebeiensine) 非竞争性拮抗气管平滑肌 M 受体，抑制 Ach 引起的平滑肌收缩。它兴奋 β 受体和拮抗内钙释放，促进一氧化氮释放，可舒张气管平滑肌，有平喘作用。

Captopril (SQ 14225) hydrochloride 是一种含巯基的口服活性血管紧张素转换酶(ACE)抑制剂，IC50值为0.025 μM，已广泛应用于高血压和充血性心力衰竭的研究。Captopril hydrochloride 也是 NDM-1抑制剂，IC50值为 7.9 μM。

Pentoprilat is a member of a series of l-glutarylindoline-2(S)-carboxylic acid derivatives. Pentopril was evaluated as an inhibitor of a cell-free preparation of angiotensin-converting enzyme (ACE) isolated from rabbit lung. Intravenous administration of incremental doses of pentopril to anesthetized normotensive rats produced a dose-related inhibition of angiotensin I (AI) pressor responses. The onset of inhibition of the A1 pressor response was rapid, and substantial inhibition occurred at 5 min after administration of the ACE inhibitors. Pentopril hydrolyzed in vivo to the biologically active free-acid form of CGS 13934. It was well tolerated in normal volunteers and hypertensive patients. Pentopril was developed for the treatment of both hypertension and congestive heart failure. Pentopril produced little clinical improvement and no biochemical improvement in a patients with rheumatoid arthritis.

H-Ile-Pro-Pro-OH hydrochloride，一种源自乳制品的三肽，通过抑制血管紧张素转换酶 (ACE)，IC50为5 μM，展现出抗高血压效果。

CaptoprilEPImpurity B 是一种 Captopril 的杂质。Captopril 是一种含巯基的口服活性血管紧张素转换酶(ACE)抑制剂 (IC50=0.025 μM)。